The goal of this program is to improve management of multiple myeloma (MM) with immunotherapy. After hearing and assimilating this program, the clinicians will be able to:Compare the toxicities associated with currently approved therapies to manage MM.Appraise the latest evidence-based data regarding available therapies for treatment of MM.Maximize MM treatment outcomes through proper sequencing and combination of therapies.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-06-11 05:00:00
- End Date: 2024-06-11 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest